- Home
- RCS vs NPCT Comparison
RCS vs NPCT Comparison
Compare RCS & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Company Overview
Basic Information| Metric | RCS | NPCT |
|---|---|---|
| Founded | 1994 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Investment Managers |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 246.0M | 286.7M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | RCS | NPCT |
|---|---|---|
| Price | $5.18 | $9.71 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 119.5K | 97.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 10.12% | 9.82% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.09 | $9.60 |
| 52 Week High | $8.00 | $11.12 |
Technical Indicators
Market Signals| Indicator | RCS | NPCT |
|---|---|---|
| Relative Strength Index (RSI) | 40.44 | 42.93 |
| Support Level | $5.10 | $9.65 |
| Resistance Level | $5.67 | $9.89 |
| Average True Range (ATR) | 0.06 | 0.09 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 7.14 | 32.00 |
Price Performance
Historical Comparison RCS
NPCT
About RCS PIMCO Strategic Income Fund Inc.
PIMCO Strategic Income Fund, Inc. operates as a closed-end management investment company. Its primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities. The Fund also seeks capital appreciation to the extent consistent with the objective.
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to provide a high level of current income.